P76.27 ORCHARD: A Biomarker-Directed Phase 2 Platform Study in pts with Advanced EGFRm NSCLC Progressing on First-Line OsimertinibB.C. Cho, Helena A. Yu, Xiuning Le et al.|Journal of Thoracic Oncology|2021Cited by 3